Dean Investment Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.28M | Sell |
94,713
-6,482
| -6% | -$170K | 0.3% | 138 |
|
|
2026
Q1 | $2.84M | Buy |
101,195
+6,465
| +7% | +$172K | 0.4% | 126 |
|
|
2025
Q4 | $2.36M | Sell |
94,730
-20,550
| -18% | -$518K | 0.34% | 134 |
|
|
2025
Q3 | $2.94M | Sell |
115,280
-4,671
| -4% | -$115K | 0.41% | 125 |
|
|
2025
Q2 | $2.91M | Buy |
119,951
+3,061
| +3% | +$71.4K | 0.43% | 119 |
|
|
2025
Q1 | $2.96M | Buy |
116,890
+20,166
| +21% | +$528K | 0.44% | 108 |
|
|
2024
Q4 | $2.57M | Sell |
96,724
-35,109
| -27% | -$952K | 0.37% | 139 |
|
|
2024
Q3 | $3.82M | Sell |
131,833
-7,618
| -5% | -$222K | 0.52% | 68 |
|
|
2024
Q2 | $3.9M | Sell |
139,451
-5,413
| -4% | -$149K | 0.55% | 69 |
|
|
2024
Q1 | $4.02M | Sell |
144,864
-1,158
| -0.8% | -$32.1K | 0.55% | 77 |
|
|
2023
Q4 | $4.2M | Sell |
146,022
-7,688
| -5% | -$232K | 0.6% | 61 |
|
|
2023
Q3 | $5.1M | Buy |
153,710
+15,778
| +11% | +$558K | 0.84% | 28 |
|
|
2023
Q2 | $5.06M | Buy |
137,932
+4,110
| +3% | +$160K | 0.82% | 34 |
|
|
2023
Q1 | $5.46M | Buy |
133,822
+14,745
| +12% | +$637K | 0.87% | 31 |
|
|
2022
Q4 | $6.1M | Sell |
119,077
-1,492
| -1% | -$71.5K | 1.04% | 14 |
|
|
2022
Q3 | $5.28M | Buy |
120,569
+2,222
| +2% | +$108K | 1.08% | 10 |
|
|
2022
Q2 | $6.21M | Sell |
118,347
-1,979
| -2% | -$101K | 1.21% | 6 |
|
|
2022
Q1 | $6.23M | Sell |
120,326
-968
| -0.8% | -$50.2K | 1.12% | 8 |
|
|
2021
Q4 | $7.16M | Sell |
121,294
-169
| -0.1% | -$8.37K | 1.26% | 3 |
|
|
2021
Q3 | $5.22M | Sell |
121,463
-410
| -0.3% | -$18.2K | 0.98% | 15 |
|
|
2021
Q2 | $4.77M | Buy |
121,873
+24,618
| +25% | +$957K | 0.88% | 20 |
|
|
2021
Q1 | $3.52M | Sell |
97,255
-2,041
| -2% | -$72.5K | 0.66% | 40 |
|
|
2020
Q4 | $3.65M | Sell |
99,296
-9,049
| -8% | -$332K | 0.76% | 36 |
|
|
2020
Q3 | $3.77M | Sell |
108,345
-2,012
| -2% | -$70.5K | 0.9% | 17 |
|
|
2020
Q2 | $3.42M | Buy |
110,357
+3,427
| +3% | +$116K | 0.82% | 27 |
|
|
2020
Q1 | $3.31M | Sell |
106,930
-2,258
| -2% | -$76.9K | 0.71% | 43 |
|
|
2019
Q4 | $4.06M | Sell |
109,188
-45,282
| -29% | -$1.61M | 0.64% | 56 |
|
|
2019
Q3 | $5.27M | Buy |
154,470
+6,963
| +5% | +$253K | 0.77% | 39 |
|
|
2019
Q2 | $6.06M | Sell |
147,507
-9
| -0% | -$357 | 0.87% | 22 |
|
|
2019
Q1 | $5.94M | Sell |
147,516
-89
| -0.1% | -$3.56K | 0.86% | 27 |
|
|
2018
Q4 | $6.11M | Buy |
147,605
+3,144
| +2% | +$131K | 0.97% | 21 |
|
|
2018
Q3 | $6.04M | Sell |
144,461
-41,537
| -22% | -$1.6M | 0.84% | 34 |
|
|
2018
Q2 | $6.4M | Sell |
185,998
-4,497
| -2% | -$154K | 0.95% | 22 |
|
|
2018
Q1 | $6.41M | Sell |
190,495
-4,552
| -2% | -$156K | 0.95% | 24 |
|
|
2017
Q4 | $6.7M | Buy |
195,047
+1,391
| +0.7% | +$47.4K | 1.02% | 12 |
|
|
2017
Q3 | $6.56M | Buy |
193,656
+10,027
| +5% | +$322K | 1% | 19 |
|
|
2017
Q2 | $5.85M | Buy |
183,629
+29,556
| +19% | +$932K | 0.89% | 30 |
|
|
2017
Q1 | $5M | Buy |
154,073
+122,566
| +389% | +$3.86M | 0.84% | 42 |
|
|
2016
Q4 | $971K | Buy |
31,507
+2,952
| +10% | +$90.1K | 0.17% | 134 |
|
|
2016
Q3 | $918K | Buy |
28,555
+2,095
| +8% | +$70.1K | 0.17% | 126 |
|
|
2016
Q2 | $884K | Buy |
26,460
+1,043
| +4% | +$33.3K | 0.17% | 125 |
|
|
2016
Q1 | $715K | Buy |
25,417
+999
| +4% | +$28.5K | 0.15% | 147 |
|
|
2015
Q4 | $748K | Buy |
24,418
+159
| +0.7% | +$5K | 0.17% | 132 |
|
|
2015
Q3 | $723K | Buy |
24,259
+1,350
| +6% | +$43.3K | 0.16% | 135 |
|
|
2015
Q2 | $729K | Buy |
22,909
+779
| +4% | +$25.4K | 0.17% | 148 |
|
|
2015
Q1 | $731K | Buy |
22,130
+1,774
| +9% | +$56.4K | 0.17% | 146 |
|
|
2014
Q4 | $602K | Buy |
20,356
+884
| +5% | +$25.3K | 0.14% | 154 |
|
|
2014
Q3 | $546K | Buy |
19,472
+610
| +3% | +$17.1K | 0.13% | 155 |
|
|
2014
Q2 | $531K | Buy |
18,862
+352
| +2% | +$10K | 0.12% | 157 |
|
|
2014
Q1 | $564K | Buy |
18,510
+911
| +5% | +$27.2K | 0.14% | 143 |
|
|
2013
Q4 | $511K | Buy |
17,599
+1,099
| +7% | +$32K | 0.12% | 156 |
|
|
2013
Q3 | $450K | Buy |
16,500
+1,761
| +12% | +$47.9K | 0.12% | 151 |
|
|
2013
Q2 | $392K | Buy |
+14,739
| New | +$407K | 0.11% | 161 |
|
Other funds holding PFE
Dean Investment Associates's PFE Position: Q2 2026 in Review
Dean Investment Associates reduced its Pfizer (PFE) stake by 6.4% in Q2 2026, selling an estimated $170K and leaving 94,713 shares worth $2.28M. The position accounts for 0.3% of the portfolio, ranked #138.
Dean Investment Associates first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.16M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Dean Investment Associates held 94,713 shares of Pfizer worth $2.28M as of Q2 2026.
- Dean Investment Associates sold 6,482 Pfizer shares in Q2 2026, an estimated $170K.
- Pfizer made up 0.3% of Dean Investment Associates's portfolio in Q2 2026, its #138 holding.
- Dean Investment Associates first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Dean Investment Associates's Pfizer position peaked at $7.16M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.